Abstract: The present invention relates to a novel process for preparing chlorobenzaldehyde oximes of the general formula (I).

Abstract: The present invention concerns proteins having improved omega-transaminase (?-TA) activity, nucleic acid molecules encoding respective proteins having improved ?-TA activity and methods for stereo selective synthesis of chiral amines and amino acids or increasing of chiral amines isomers in enantiomer mixtures.

Abstract: The present invention primarily relates to a process for producing certain substituted 2-allylanilines of the hereinbelow-defined formula (I) and their use in a process for producing substituted 4-aminoindane derivatives of the hereinbelow-defined formula (V). The present invention further relates to a process for producing fungicidal indanyl carboxamides. In particular, the present invention relates to a process for producing 2-(difluoromethyl)-N-(1,1-dimethyl-3-propyl-2,3-dihydro-1H-inden-4-yl)nicotinamide and/or 3-(difluoromethyl)-N-[(R)-2,3-dihydro-1,1,3-trimethyl-1H-inden-4-yl]-1-methylpyrazole-4-carboxamide.

Abstract: The present invention relates to a process for preparing compounds of the formula (I) starting from compounds of the formula (II) in which R1, R2 and R3 have the abovementioned meaning and where R1 and R3 are not simultaneously hydrogen in any compound. The invention further provides the compounds of the formulae (IVa), (IVb), (V) and (VI) in which R1, R2, R3, R5, M and n have the abovementioned meaning.

Abstract: The present invention relates to a process for preparing compounds of the formula (I) starting from compounds of the formula (II) wherein X, R1, R2, R3, R4, U, A1, A2, A3 and A4 are defined as described above. The invention relates to compounds of the formulae (III) and (IV) wherein all variables are defined as above.

Abstract: The present invention relates to disubstituted 3-pyrazole carboxylates of the formula (I) and a process for their preparation wherein R1, R2, R3, R4 and n are defined as above.

Abstract: The present invention relates primarily to a process for preparing certain phosphorus-containing cyanohydrins of the formula (I), and also to certain phosphorus-containing cyanohydrins per se and to their use for the preparation of glufosinate and/or glufosinate salts. The present invention further relates to certain mixtures particularly suitable for preparing the phosphorus-containing cyanohydrins of the formula (I).

Abstract: The present invention primarily relates to a process for producing certain phosphorus-containing cyanohydrin esters of formula (I) and the use thereof for producing glufosinate/glufosinate salts. The present invention further relates to a process for producing glufosinate/glufosinate salts.

Abstract: The invention relates to a method for preparing methyl 4-[(4,5-dihydro-3-methoxy-4-methyl-5-oxo-1H-1,2,4-triazol-1-yl)carbonyl)sulfamoyl]-5-methylthiophene-3-carboxylate from 4-methoxycarbonyl-2-methylthiophene-3-sulfonyl chloride in the presence of an imidazole base substituted in the 1-position or in the presence of a mixture of bases comprising an imidazole base substituted in the 1-position (N-alkylimidazole).

Abstract: The present invention relates primarily to processes for preparing particular phosphorus-containing ?-aminonitriles of the formulae (Ia) and (Ib) defined hereinafter from corresponding phosphorus-containing cyanohydrin esters and to the use thereof for preparation of glufosinate or of glufosinate salts. The present invention further relates to a process for preparing glufosinate or glufosinate salts.

Abstract: The present invention relates to a method for preparing substituted 2,3-dihydro-l-benzofuran derivatives.

Abstract: The present invention relates to a method for preparing substituted 2,3-dihydro-1-benzofuran derivatives.

Abstract: The present invention relates primarily to processes for preparing particular phosphorus-containing ?-aminonitriles of the formulae (Ia) and (Ib) defined hereinafter from corresponding phosphorus-containing cyanohydrin esters and to the use thereof for preparation of glufosinate or of glufosinate salts. The present invention further relates to a process for preparing glufosinate or glufosinate salts.

Abstract: The present invention relates to a method for preparing 3-substituted 2-vinylphenyl sulfonates.

Abstract: The present invention relates to a new process for preparing 3-chloro-2-vinylphenylsulfonate derivatives.

Abstract: The present invention primarily relates to a process for producing certain phosphorus-containing cyanohydrin esters of formula (I) and the use thereof for producing glufosinate/glufosinate salts. The present invention further relates to a process for producing glufosinate/glufosinate salts.

Abstract: The present invention relates to a method for preparing 3-substituted 2-vinylphenyl sulfonates.

Abstract: The invention relates to a method for preparing methyl 4-[(4,5-dihydro-3-methoxy-4-methyl-5-oxo-1H-1,2,4-triazol-1-yl)carbonyl)sulfamoyl]-5-methylthiophene-3-carboxylate from 4-methoxycarbonyl-2-methylthiophene-3-sulfonyl chloride in the presence of an imidazole base substituted in the 1-position or in the presence of a mixture of bases comprising an imidazole base substituted in the 1-position (N-alkylimidazole).

Abstract: A process for producing biguanidine salts of formula (III) and s-triazines of formula (V) is described. Therein, R1 and R2 are in each case hydrogen, halogen and alkyl, and R3 and R4 are in each case hydrogen, alkyl, cycloalkyl and aryl.

Abstract: The present invention generally relates to improved processes for the preparation of amphiphilic imidazolinium compounds such as 1-[2-(9(Z)-octadecenoyloxy)ethyl]-2-(8(Z)-heptadecenyl)-3-(2-hydroxyethyl)imidazolinium chloride (DOTIM). In particular, the invention relates to processes for the synthesis of such compounds that avoid the need for toxic reagents, are more economical, and result in less waste than conventional methods. DOTIM and similar compounds can be formulated as cationic liposomes, which are useful as chemical vectors for nucleic acid delivery in gene therapy.